thymic-factor--circulating and Empyema--Pleural

thymic-factor--circulating has been researched along with Empyema--Pleural* in 1 studies

Other Studies

1 other study(ies) available for thymic-factor--circulating and Empyema--Pleural

Article	Year
[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications]. Khirurgiia, 1996, Issue:2 The influence of immunoactive medicines on the cell immunity have been studied. There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications. Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only. T-activin led to the increase in the number of T-lymphocytes and B-lymphocytes independently of it's cooperation with the vaccines. The stimulating effect of myelopid demonstrated itself by increase in the number of B-lymphocytes and immunoglobulins M and G after 14 days of treatment. The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters. Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Empyema, Pleural; Humans; Immunoglobulins; Lymphocyte Subsets; Oligopeptides; Osteomyelitis; Peptides; Peritonitis; Phagocytosis; Postoperative Complications; Suppuration; Surgical Wound Infection; Thymus Extracts; Thymus Hormones; Time Factors	1996

Article

Year

[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].

Khirurgiia, 1996, Issue:2

The influence of immunoactive medicines on the cell immunity have been studied. There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications. Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only. T-activin led to the increase in the number of T-lymphocytes and B-lymphocytes independently of it's cooperation with the vaccines. The stimulating effect of myelopid demonstrated itself by increase in the number of B-lymphocytes and immunoglobulins M and G after 14 days of treatment. The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters.

Topics: Activins; Adjuvants, Immunologic; Bone Marrow; Empyema, Pleural; Humans; Immunoglobulins; Lymphocyte Subsets; Oligopeptides; Osteomyelitis; Peptides; Peritonitis; Phagocytosis; Postoperative Complications; Suppuration; Surgical Wound Infection; Thymus Extracts; Thymus Hormones; Time Factors

1996